Which has grown faster, EDIT or KMDA?

Over the past five years, KMDA grew revenue faster — EDIT at a -10.34% CAGR versus KMDA at 10.59%.

Does EDIT or KMDA pay a bigger dividend?

KMDA pays a dividend (5.25% yield), while EDIT has no payments in the available dividend history.

Is EDIT or KMDA more profitable?

KMDA runs the higher net margin — EDIT at -157.32% versus KMDA at 11.60%.

How have EDIT and KMDA total returns compared?

Over the past 10 years, EDIT delivered -15.75% and KMDA delivered 5.44% annualized total return. Past performance doesn't predict future results.

Editas Medicine, Inc. (EDIT) vs Kamada Ltd. (KMDA)

A side-by-side comparison of Editas Medicine, Inc. and Kamada Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EDIT

Editas Medicine, Inc.

$423M

$2.76HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

KMDA

Kamada Ltd.

$458M

$7.94HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT

Total return — EDIT vs KMDA

growth of $100 · dividends reinvested · last 10y

EDIT -81.4% (-15.5%/yr)KMDA +65.0% (+5.1%/yr)KMDA compounded faster over this window

Log scale — wide-divergence pair

EDIT KMDA

EDIT vs KMDA: by the numbers

•KMDA is the larger company ($458M vs $423M market cap).
•KMDA is profitable (11.60% net margin) while EDIT runs a net loss (-157.32%).
•KMDA grew revenue faster over the past five years (10.59% vs -10.34% CAGR).
•KMDA pays a dividend (5.25% yield), while EDIT has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	EDIT	KMDA
P/E ratio	N/A	20.94
Forward P/E	N/A	16.62
P/S ratio	8.99	2.39
P/B ratio	4.02	1.70
EV / EBITDA	N/A	10.20
FCF yield	N/A	5.79%

Profitability

Metric	EDIT	KMDA
Gross margin	100.00%	40.82%
Operating margin	-245.15%	14.51%
Net margin	-157.32%	11.60%
ROE	-70.24%	8.25%
ROIC	-48.61%	6.95%

Dividends

Metric	EDIT	KMDA
Dividend yield	N/A	5.25%
Payout ratio	N/A	110.82%

Growth (annualized)

Metric	EDIT	KMDA
Revenue CAGR (5Y)	-10.34%	10.59%
EPS CAGR (5Y)	N/A	-1.98%
FCF CAGR (5Y)	N/A	40.37%
Total return CAGR (5Y)	-40.76%	10.36%

Frequently asked

Which has grown faster, EDIT or KMDA?: Over the past five years, KMDA grew revenue faster — EDIT at a -10.34% CAGR versus KMDA at 10.59%.
Does EDIT or KMDA pay a bigger dividend?: KMDA pays a dividend (5.25% yield), while EDIT has no payments in the available dividend history.
Is EDIT or KMDA more profitable?: KMDA runs the higher net margin — EDIT at -157.32% versus KMDA at 11.60%.
How have EDIT and KMDA total returns compared?: Over the past 10 years, EDIT delivered -15.75% and KMDA delivered 5.44% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EDIT analysis Full KMDA analysis Interactive comparison tool

Dig into the metrics

Kamada P/E ratio Kamada dividend yield Editas Medicine ROE Kamada ROE Editas Medicine operating margin Kamada operating margin Editas Medicine revenue growth Kamada revenue growth Editas Medicine free cash flow Kamada free cash flow

Editas Medicine & Kamada appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.